80 FR 79348 - Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIAID)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 244 (December 21, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 244 (December 21, 2015)
| Page Range | 79348-79349 | |
| FR Document | 2015-31986 |
[Federal Register Volume 80, Number 244 (Monday, December 21, 2015)] [Notices] [Pages 79348-79349] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-31986] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIAID) SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health, has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on October 1, 2015, 80 FR 59168 and allowed 60-days for [[Page 79349]] public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. DATES: Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Ms. Dione Washington, Health Science Policy Analyst, Office of Strategic Planning, Initiative Development and Analysis, 5601 Fishers Lane, Rockville, Maryland 20892, or call a non- toll-free number 240 669 2100 or Email your request, including your address to [email protected]. Formal requests for additional plans and instruments must be requested in writing. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIAID), 0925-0668, Expiration Date 1/31/2016, EXTENSION, National Institute of Allergy and Infectious Diseases (NIAID). Need and Use of Information Collection: There are no changes being requested for this submission. The proposed information collection activity provides a means to garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration's commitment to improving service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions, but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This feedback will provide information about the NIAID's customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between the NIAID and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 16,100. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Annual frequency Hours per Type of collection respondents per response response Total hours ---------------------------------------------------------------------------------------------------------------- Estimated Annual Reporting Burden ---------------------------------------------------------------------------------------------------------------- Customer satisfaction surveys....... 25,000 1 30/60 12,500 In-Depth Interviews (IDIs) or Small 500 1 90/60 750 Discussion Groups.................. Individual Brief Interviews......... 200 1 15/60 50 Focus Groups........................ 1,000 1 2 2,000 Pilot testing surveys............... 200 1 30/60 100 Conferences and Training Pre- and 1,000 1 30/60 500 Post-surveys....................... Website or Software Usability Tests. 100 1 2 200 --------------------------------------------------------------------------- Total........................... 28,000 ................. ................. 16,100 ---------------------------------------------------------------------------------------------------------------- Dated: December 15, 2015. Brandie Taylor Bumgardner, Project Clearance Liaison, NIAID, NIH. [FR Doc. 2015-31986 Filed 12-18-15; 8:45 am] BILLING CODE 4140-01-P
![79348 Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
Number of
Number of Total burden per Total burden
Form name responses per
respondents responses response hours
respondent (in hours)
Form 1: Demographic, Service Utilization, and Clinical In-
dicators Data .................................................................... 56 1 56 425 23,800
Form 2: Performance and System Outcome Benchmark
Data .................................................................................. 56 1 56 425 23,800
Total .............................................................................. 56 ........................ 56 ........................ 47,600
Jackie Painter, fluorescence excitation and emission Inventors
Director, Division of the Executive Secretariat. peaks. The fluorescence intensity can be • Keir Neuman, Ambika Bumb, Han
[FR Doc. 2015–31936 Filed 12–18–15; 8:45 am] readily controlled by the size of the Wen, Jennifer Hong and Susanta
BILLING CODE 4165–15–P FND, the number of fluorescent centers Sarkar (all of NHLBI)
produced in the nanodiamonds, or in • Chang Yi, Lawrence Samelson, Asit
situ through the application of a weak Manna (all of NCI)
DEPARTMENT OF HEALTH AND magnetic field. The particular advantage Intellectual Property: HHS Reference
HUMAN SERVICES of the FND compositions of this No. E–217–2015/0–US–01
invention are that they are particularly • US Provisional Patent Application 62/
National Institutes of Health useful for extended imaging of a single 262,058 filed December 2, 2015.
sample over time periods that can be as Licensing Contact: Michael
Government-Owned Inventions;
long as a week or more. In an exemplary Shmilovich, Esq, CLP; 301–435–5019;
Availability for Licensing
embodiment, FNDs are immobilized in shmilovm@mail.nih.gov.
AGENCY: National Institutes of Health, a substrate that are coated with an inert Collaborative Research Opportunity:
HHS. top coating, like silicon dioxide, or The National Heart, Lung and Blood
ACTION: Notice. transparent polymer (e.g. poly-L-lysine, Institute seeks statements of capability
poly-L-arginine, or siloxanes). or interest from parties interested in
SUMMARY: The inventions listed below Generally, any suitable methods known collaborative research to further develop
are owned by an agency of the U.S. for surface functionalization of the and evaluate metallic nanoparticle
Government and are available for substrate can be used to make the vesicles for cancer phototherapy. For
licensing in the U.S. in accordance with composition. In another aspect of this collaboration opportunities, please
35 U.S.C. 209 and 37 CFR part 404 to invention, the inventors designed contact Vincent Kolesnitchenko, Ph.D.
achieve expeditious commercialization software for super-resolution imaging at kolesniv@nhlbi.nih.gov.
of results of federally-funded research correction method is employed to
and development. Foreign patent Dated: December 15, 2015.
precisely determine the position
applications are filed on selected Michael Shmilovich,
coordinates of each of a set of FNDs in
inventions to extend market coverage Senior Licensing and Patenting Manager,
a plurality of images by using Gaussian
for companies and may also be available National Heart, Lung, and Blood Institute,
fitting of the point spread function Office of Technology Transfer and
for licensing. comprises each of the FNDs in the Development.
FOR FURTHER INFORMATION CONTACT: plurality of images. The calculated [FR Doc. 2015–31890 Filed 12–18–15; 8:45 am]
Licensing information and copies of the correction is then used to displace each BILLING CODE 4140–01–P
U.S. patent applications listed below image to align the coordinates of the
may be obtained by emailing the FNDs. The positions of the FNDs can be
indicated licensing contact at the tracked with sub-nanometer precision DEPARTMENT OF HEALTH AND
National Heart, Lung, and Blood, Office and residual drift can be reduced to the HUMAN SERVICES
of Technology Transfer and nanometer scale over hundreds of hours
Development Office of Technology of tracking. National Institutes of Health
Transfer, 31 Center Drive Room 4A29,
MSC2479, Bethesda, MD 20892–2479; Potential Commercial Applications Submission for OMB Review; 30-Day
telephone: 301–402–5579. A signed • Fluorescent Microscopy Comment Request; Generic Clearance
Confidential Disclosure Agreement may • Super-resolution microscopy for the Collection of Qualitative
be required to receive copies of the • Correlative imaging techniques Feedback on Agency Service Delivery
patent applications. combing fluorescence microscopy (NIAID)
SUPPLEMENTARY INFORMATION: with electron, x-ray, or atomic force
microscopy imaging modalities SUMMARY: Under the provisions of
Technology description follows. Section 3507(a)(1)(D) of the Paperwork
Fluorescent Nanodiamonds as Fiducial Competitive Advantages Reduction Act of 1995, the National
mstockstill on DSK4VPTVN1PROD with NOTICES
Markers for Microscopy • Non-blinking, Non-bleaching Institutes of Health, has submitted to the
• Chemically inert Office of Management and Budget
Description of Technology
• Chemically and physically stable (OMB) a request for review and
The invention relates to fluorescent • Broad excitation approval of the information collection
nanodiamonds (FNDs) and their uses as • Longevity listed below. This proposed information
fiducial markers for microscopy. FNDs collection was previously published in
are bright fluorescent probes that do not Development Stage the Federal Register on October 1, 2015,
blink or bleach and have broad • In vitro data 80 FR 59168 and allowed 60-days for
VerDate Sep<11>2014 17:38 Dec 18, 2015 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\21DEN1.SGM 21DEN1](https://thefederalregister.org/doc/80_FR_79592/page/1.svg)
![Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices 79349
public comment. No public comments plans and instruments, or request more accordance with the Administration’s
were received. The purpose of this information on the proposed project, commitment to improving service
notice is to allow an additional 30 days contact: Ms. Dione Washington, Health delivery. By qualitative feedback we
for public comment. The National Science Policy Analyst, Office of mean information that provides useful
Institute of Allergy and Infectious Strategic Planning, Initiative insights on perceptions and opinions,
Diseases (NIAID), National Institutes of Development and Analysis, 5601 but are not statistical surveys that yield
Health, may not conduct or sponsor, Fishers Lane, Rockville, Maryland quantitative results that can be
and the respondent is not required to 20892, or call a non-toll-free number generalized to the population of study.
respond to, an information collection 240 669 2100 or Email your request, This feedback will provide information
that has been extended, revised, or including your address to about the NIAID’s customer or
implemented on or after October 1, washingtondi@niaid.nih.gov. Formal stakeholder perceptions, experiences
1995, unless it displays a currently valid requests for additional plans and
OMB control number. and expectations, provide an early
instruments must be requested in
Direct Comments to OMB: Written warning of issues with service, or focus
writing. Formal requests for additional
comments and/or suggestions regarding attention on areas where
plans and instruments must be
the item(s) contained in this notice, requested in writing. communication, training or changes in
especially regarding the estimated Proposed Collection: Generic operations might improve delivery of
public burden and associated response Clearance for the Collection of products or services. These collections
time, should be directed to the: Office Qualitative Feedback on Agency Service will allow for ongoing, collaborative and
of Management and Budget, Office of Delivery (NIAID), 0925–0668, actionable communications between the
Regulatory Affairs, OIRA_submission@ Expiration Date 1/31/2016, NIAID and its customers and
omb.eop.gov or by fax to 202–395–6974, EXTENSION, National Institute of stakeholders. It will also allow feedback
Attention: NIH Desk Officer. Allergy and Infectious Diseases (NIAID). to contribute directly to the
DATES: Comment Due Date: Comments Need and Use of Information improvement of program management.
regarding this information collection are Collection: There are no changes being OMB approval is requested for 3
best assured of having their full effect if requested for this submission. The years. There are no costs to respondents
received within 30 days of the date of proposed information collection activity other than their time. The total
this publication. provides a means to garner qualitative estimated annualized burden hours are
FOR FURTHER INFORMATION CONTACT: To customer and stakeholder feedback in
16,100.
obtain a copy of the data collection an efficient, timely manner, in
ESTIMATED ANNUALIZED BURDEN HOURS
Number of Annual frequency Hours per
Type of collection Total hours
respondents per response response
Estimated Annual Reporting Burden
Customer satisfaction surveys ................................................. 25,000 1 30/60 12,500
In-Depth Interviews (IDIs) or Small Discussion Groups .......... 500 1 90/60 750
Individual Brief Interviews ........................................................ 200 1 15/60 50
Focus Groups .......................................................................... 1,000 1 2 2,000
Pilot testing surveys ................................................................. 200 1 30/60 100
Conferences and Training Pre- and Post-surveys .................. 1,000 1 30/60 500
Website or Software Usability Tests ....................................... 100 1 2 200
Total .................................................................................. 28,000 .............................. .............................. 16,100
Dated: December 15, 2015. proposed collections of information, the ways to minimize the burden of the
Brandie Taylor Bumgardner, Substance Abuse and Mental Health collection of information on
Project Clearance Liaison, NIAID, NIH. Services Administration (SAMHSA) respondents, including through the use
[FR Doc. 2015–31986 Filed 12–18–15; 8:45 am] will publish periodic summaries of of automated collection techniques or
proposed projects. To request more other forms of information technology.
BILLING CODE 4140–01–P
information on the proposed projects or
Proposed Project: Community Support
to obtain a copy of the information
Evaluation (CSE)—New
DEPARTMENT OF HEALTH AND collection plans, call the SAMHSA
HUMAN SERVICES Reports Clearance Officer on (240) 276– The Substance Abuse and Mental
1243. Health Services Administration
Substance Abuse and Mental Health Comments are invited on: (a) Whether (SAMHSA), Center for Mental Health
Services Administration the proposed collections of information Services (CMHS), is requesting
are necessary for the proper clearance for the new data collection
mstockstill on DSK4VPTVN1PROD with NOTICES
Agency Information Collection performance of the functions of the associated with the CSE. The CSE is a
Activities: Proposed Collection; agency, including whether the multicomponent evaluation of two
Comment Request information shall have practical utility; SAMHSA programs—Behavioral Health
(b) the accuracy of the agency’s estimate Treatment Court Collaborative (BHTCC)
In compliance with Section of the burden of the proposed collection and Transforming Lives through
3506(c)(2)(A) of the Paperwork of information; (c) ways to enhance the Supported Employment (SE). SE intends
Reduction Act of 1995 concerning quality, utility, and clarity of the to promote recovery for individuals
opportunity for public comment on information to be collected; and (d) with serious mental illness, substance
VerDate Sep<11>2014 17:38 Dec 18, 2015 Jkt 238001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\21DEN1.SGM 21DEN1](https://thefederalregister.org/doc/80_FR_79592/page/2.svg)
Document Created: 2015-12-19 02:56:58
Document Modified: 2015-12-19 02:56:58
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Ms. Dione Washington, Health Science Policy Analyst, Office of Strategic Planning, Initiative Development and Analysis, 5601 Fishers Lane, Rockville, Maryland 20892, or call a non- toll-free number 240 669 2100 or Email your request, including your | |
| FR Citation | 80 FR 79348 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR